James F. Oliviero III, CEO, President and Director at Checkpoint Therapeutics, Inc. (CKPT), sold 24,850 shares at $2.01 ($24K) on 2024-02-01, disclosed to the SEC on 2024-02-02.
Seasonal sale ($24k) by CEO, President and Director — this insider has traded CKPT in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 12,950 | $0 | 0.0% |
| 2 | $2.01 | 11,900 | $24K | 100.0% |
| Total | $0.96 avg | 24,850 | $24K | 100% |
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |